The number of Americans taking cutting-edge weight-loss drugs like Ozempic, Wegovy and Zepbound has skyrocketed in recent ...

Abbott Laboratories, a global healthcare giant, develops and markets a broad range of medical devices, diagnostics, branded generic medicines, and nutritional products. Its strong focus on innovation ...

Next-gen weight-loss drugs like CagriSema and UBT251 could hit shelves within a year, promising more effective obesity and diabetes treatments.

The Drug Repurposing Market was USD 35.33 Bn in 2024 and is expected to expand at a CAGR of 4.9 % from 2025 to 2032, reaching USD 51.80 Bn by 2032. The U.S. FDA approved Bristol-Myers Squibb’s ...

(MENAFN- GlobeNewsWire - Nasdaq) The U.S. commercial weight loss market has reached $38 billion in 2024, up 15% from 2020, but has been significantly disrupted by the rise of GLP-1 weight loss ...

Eli Lilly launched its blockbuster diabetes and weight-loss drug Mounjaro in India on Thursday, beating rival Novo Nordisk ...

The Danish drugmaker had said it aims to launch its blockbuster weight-loss drug, Wegovy, in India by 2026. The active ...

It’s not just for the celebrities anymore. The ‘miracle’ weight loss drug race has arrived in India with the launch of American drugmaker Eli Lilly’s Mounjaro last week. Priced at ...